NB
Nascent Biotech, Inc.
NBIO · OTC
$0.00 +0.00% (+$0.00)
1M -33.33%
Market Cap $34.4K
P/E Ratio -
Div. Yield -
ROE -
Piotroski F-Score Weak
1/9Valuation
0 /100
Expensive P/S 11,481.10x
P/E N/A
EV/EBITDA N/A
Growth
-
N/A EPS growth N/A
Rev. growth N/A
FCF growth N/A
Profitability
0 /100
Weak Gross margin 9,854,200.00%
Net margin 44,926,500.00%
Op. margin 50,236,100.00%
Quality
57 /100
Average ROIC 213.86%
ROA 741.27%
Asset turnover 0.00x
Debt
0 /100
High Current ratio 0.19x
Int. coverage -59.09x
Debt/Equity N/A
Stability
5 /100
Unstable Beta 1.76x
EPS volatility 283.98%
Profitable years 0
Bulios Scoring opisuje jakość i historię firmy, a nie przyszły zwrot. Wysoki wynik to nie sygnał zakupu. Dowiedz się więcej
Zapytaj StockBota o NBIO
Online
Sector
Healthcare
Industry
Biotechnology
CEO
Sean Carrick
Employees
2
Headquarters
North Palm Beach